Key Takeaways
- • Todd Boehly and Mark Walter are reportedly selling their combined 25.6% stake in Chelsea to Clearlake for around £950m, implying a club valuation of approximately £5bn including debt, according to reports cited in the source article.
- • The reported £5bn implied valuation compares with Forbes estimates of $3.1bn in 2022 and $4.2bn in 2026, and represents a transaction between existing investors rather than an external estimate.
- • BlueCo's purchase agreement bars an external sale until 2032, so any transaction before then is restricted to existing BlueCo shareholders, which the author argues undervalues the club's potential open-market price at exit.
- • The author frames Chelsea as a long-term asset-development play: heavy investment in young players, Strasbourg as a development channel, and more than €1bn in player sales since 2022, with squad valuation rising from about €1.02bn to €1.42bn.
- • The author states that the key test is whether aggregate asset value and exit proceeds exceed capital deployed, financing, and operating costs, with debt at roughly £1.4bn.
Summary
A commentary piece by a self-described Chelsea fan with private equity industry experience assesses BlueCo's ownership of Chelsea as an investment rather than a football project. The author outlines a conventional private equity playbook of acquiring cheaply, restructuring, extracting cash and exiting within about five years, and argues that BlueCo's 2032 restriction on external sales makes its approach materially different.
The author cites a reported sale of Todd Boehly and Mark Walter's combined 25.6% stake to Clearlake for around £950m, which would imply a Chelsea valuation of approximately £5bn including debt. The author notes that the stake was originally worth roughly £640m on the basis of the 2022 purchase, a reported gain of about £310m (+48%), though the precise return cannot be calculated without knowing subsequent capital contributions. Clearlake would be acquiring the remaining interests of two original partners to effectively take full control. The author describes this as an actual transaction between investors, in contrast to the Forbes estimates of approximately $3.1bn in 2022 and $4.2bn in 2026.
On asset value, the author argues that squad valuation rose from about €1.02bn in 2022 to about €1.42bn after the 2026 window, with an average age of 23.3, while more than €1bn of player sales were completed in the period. Strasbourg is cited as evidence of an asset-development model, with roughly €200m of reported transfer receipts against about €99m of spending in the 2026 summer window, including sales of Diego Moreira (€50m), Valentín Barco (€40m) and Julio Enciso (around €30m). The author acknowledges that wages, operating costs, financing and transfer costs must be netted before profitability can be judged.
The author compares Chelsea's appreciation with other sporting assets, including Liverpool, Aston Villa, the Boston Celtics and the LA Lakers, and cites Everton, where the Friedkin Group is reportedly exploring a sale at a potential valuation of around £800m including debt, an unproven figure. The author describes these as non-comparable investments.
Looking ahead, the author argues that an open-market sale in 2032 could attract multiple bidders and a higher price, and that BlueCo is likely betting on a valuation closer to £10bn. The author is sceptical that a new stadium will be built before 2032, suggesting planning and construction would consume most of the period. The author also notes that the key financial question is whether asset value and exit proceeds exceed capital deployed and costs, and that a hypothetical £6bn enterprise value would still require deduction of debt, shareholder claims, operating losses, financing costs and transaction expenses. The piece is an opinion column and its valuation figures are reported estimates rather than confirmed transaction data.
The author cites a reported sale of Todd Boehly and Mark Walter's combined 25.6% stake to Clearlake for around £950m, which would imply a Chelsea valuation of approximately £5bn including debt. The author notes that the stake was originally worth roughly £640m on the basis of the 2022 purchase, a reported gain of about £310m (+48%), though the precise return cannot be calculated without knowing subsequent capital contributions. Clearlake would be acquiring the remaining interests of two original partners to effectively take full control. The author describes this as an actual transaction between investors, in contrast to the Forbes estimates of approximately $3.1bn in 2022 and $4.2bn in 2026.
On asset value, the author argues that squad valuation rose from about €1.02bn in 2022 to about €1.42bn after the 2026 window, with an average age of 23.3, while more than €1bn of player sales were completed in the period. Strasbourg is cited as evidence of an asset-development model, with roughly €200m of reported transfer receipts against about €99m of spending in the 2026 summer window, including sales of Diego Moreira (€50m), Valentín Barco (€40m) and Julio Enciso (around €30m). The author acknowledges that wages, operating costs, financing and transfer costs must be netted before profitability can be judged.
The author compares Chelsea's appreciation with other sporting assets, including Liverpool, Aston Villa, the Boston Celtics and the LA Lakers, and cites Everton, where the Friedkin Group is reportedly exploring a sale at a potential valuation of around £800m including debt, an unproven figure. The author describes these as non-comparable investments.
Looking ahead, the author argues that an open-market sale in 2032 could attract multiple bidders and a higher price, and that BlueCo is likely betting on a valuation closer to £10bn. The author is sceptical that a new stadium will be built before 2032, suggesting planning and construction would consume most of the period. The author also notes that the key financial question is whether asset value and exit proceeds exceed capital deployed and costs, and that a hypothetical £6bn enterprise value would still require deduction of debt, shareholder claims, operating losses, financing costs and transaction expenses. The piece is an opinion column and its valuation figures are reported estimates rather than confirmed transaction data.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.